FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to oncology, and can be used for increasing content of high-differentiated cells in breast tumour biopsy material. Composition for increasing content of high-differentiated cells in breast tumour biopsy material contains phytohaemagglutinin P (PHA-P) - 1.6–2.4 mcg/ml, phytohemagglutinin M - 1.6–2.4 mcg/ml, concanavalin A - 3.2–4.8 mcg/ml, lipopolysaccharide from Escherichia coli - 1.6–2.4 mcg/ml in ratio (pts.wt) 1/1/2/1 respectively. Tumour is an invasive protocol cancer, which is a histological type of grade II and III adenocarcinoma.
EFFECT: using the given invention allows increasing the content of high-differentiated cells in breast adenocarcinoma after the composition effect.
1 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF THE EFFECTIVENESS OF THE AGENT FOR INCREASING THE HIGH-DIFFERENTIATED CELLS IN MAMMARY ADENOCARCINOMA AND THE COMPOSITION FOR ITS IMPLEMENTATION | 2018 |
|
RU2705398C1 |
| MEDICAL PRODUCT REDUCING CONTENT OF POORLY DIFFERENTIATED CELLS AND INCREASING CONTENT OF HIGHLY DIFFERENTIATED CELLS IN NON-SPECIFIC INVASIVE BREAST CARCINOMA | 2019 |
|
RU2743710C1 |
| AGENT REDUCING RELATIVE CONTENT OF LOW-DIFFERENTIATED CELLS AND INCREASING RELATIVE CONTENT OF HIGH-DIFFERENTIATED CELLS IN INVASIVE MAMMARY GLAND CARCINOMA OF NON-SPECIFIC TYPE | 2022 |
|
RU2786528C1 |
| METHOD OF INHIBITING GROWTH OF TUMOR CELLS OF PROSTATE CANCER | 2023 |
|
RU2823563C1 |
| RECOMBINANT PLASMID pET-15b_T3_RL DNA PROVIDING SYNTHESIS OF RECOMBINANT FUSION PROTEIN CONSISTING OF TUMOR-SPECIFIC PEPTIDES AND ANTITUMOR PEPTIDE RL2, AND RECOMBINANT FUSION PROTEIN POSSESSING ANTI-TUMOR ACTIVITY AGAINST HUMAN BREAST CANCER | 2016 |
|
RU2619053C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSTICS OF ADENOMA WITH III DEGREE DYSPLASIA AND EARLY COLON ADENOCARCINOMA | 2016 |
|
RU2638805C1 |
| METHOD FOR PREOPERATIVE PREDICTION OF THE RISK OF RECURRENCE IN PATIENTS WITH STAGE T1 ENDOMETRIAL CANCER | 2021 |
|
RU2762493C1 |
| METHOD FOR PRODUCTION OF IN VITRO POPULATIONS OF ACTIVATED ANTIGENSPECIFIC ANTITUMOR-TUMOR CYTOTOXIC T-LYMPHOCYTES SPECIFIC TO TUMOR-ASSOCIATED ANTIGEN EPITOPES | 2016 |
|
RU2619186C1 |
| IMMUNOTHERAPY OF BREAST CANCER USING ANTIGEN-ACTIVATED DENDRITIC CELLS | 2016 |
|
RU2645464C1 |
| METHOD OF PREDICTING THE DEVELOPMENT OF METASTASES IN PATIENTS WITH UNRESECTABLE TRIPLE-NEGATIVE BREAST CANCER | 2023 |
|
RU2802141C1 |
